If your favorite internet doctor seems to have a weirdly intense vendetta against compounded or non-branded GLP-1s, a new Washington Post investigation may help explain part of the environment they are operating in.
Find obesity and metabolic clinical trials that may be relevant to you, then connect directly with the study team when contact information is available.
Find My Trial3,981 recruiting studies tracked across 471 treatments — sourced from ClinicalTrials.gov.
The most-read On The Pen stories, ranked by reader engagement.
Novo will aslo add the tagline “Lasting health starts now”… Here’s how they could actually make that a reality.
For roughly 48 hours last week, patients could buy Zepbound auto-injector pens on Amazon Pharmacy for $399, a full $100 below the price many had been paying through Lilly’s savings card program.
On The Pen's flagship podcast — obesity medicine, unfiltered.
Obesity.News
Breaking GLP-1 news, drug development, access updates, and patient-centered analysis, all in one place.
Empowering you to have better conversations with your doctor.
On The Pen covers obesity medicine from the patient's side of the exam table — GLP-1s, access, and the science, reported plainly.
Sponsors & Partners
